In the past decade, the standards of clinical trials in China have moved closer to
international standards, thus encouraging the development of innovative drugs. However, a …

Importance Lung cancer is the leading cause of cancer death in the United States in all
ethnic and racial groups. The overall death rate from lung cancer is higher in black patients …

Introduction To address the lack of genomic data from Hispanic/Latino (H/L) patients with
lung cancer, the Latino Lung Cancer Registry was established to collect patient data and …

Background. Incorporation of molecular analysis of the epidermal growth factor receptor
(EGFR) gene into routine clinical practice represents a milestone for personalized therapy of …

Genetic mutations and metabolic reprogramming are two key hallmarks of cancer, required
for proliferation, invasion, and metastasis of the disease. While genetic mutations, whether …

Background Lung cancer is the leading cause of cancer-related death worldwide. Shorter
survival has been repeatedly reported for patients of African ancestry. Multivariate analysis …

Background Limited data are available on the prevalence of oncogenic driver mutations in
Caucasian populations, and especially in Europeans. Aim To evaluate the targetable …

Context: Trends in epidermal growth factor receptor (EGFR) mutation based on ethnicity
assist the initial selection of targeted therapy regimen. Reported incidence of EGFR mutation …